Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Analytical Scientist
  • Explore

    Explore

    • Latest
    • News & Research
    • Trends & Challenges
    • Keynote Interviews
    • Opinion & Personal Narratives
    • Product Profiles
    • App Notes
    • The Product Book

    Featured Topics

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy

    Issues

    • Latest Issue
    • Archive
  • Topics

    Techniques & Tools

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy
    • Microscopy
    • Sensors
    • Data and AI

    • View All Topics

    Applications & Fields

    • Clinical
    • Environmental
    • Food, Beverage & Agriculture
    • Pharma and Biopharma
    • Omics
    • Forensics
  • People & Profiles

    People & Profiles

    • Power List
    • Voices in the Community
    • Sitting Down With
    • Authors & Contributors
  • Business & Education

    Business & Education

    • Innovation
    • Business & Entrepreneurship
    • Career Pathways
  • Events
    • Live Events
    • Webinars
  • Multimedia
    • Video
    • Content Hubs
Subscribe
Subscribe

False

The Analytical Scientist / Power List / 2021 / Power List / Martin Gilar

Martin Gilar

Scientific Fellow, Separations R&D group, Waters Corporation, Milford, Massachusetts, USA

  • Profile

Meet Martin Gilar

In another life… My teenage aspirations were to spend most of my time on my computer, and grow long hair my parents would not approve of. During the pandemic in 2019-2020, I came dangerously close. That being crossed off my list, I need to come up with a new plan. Write a science-fiction novel? Prospect for gold and minerals? Fly into outer space? I am working on it.

Biggest challenge… I think it is the challenge of LC education. Universities are educating very few chromatographers. The pharma, biopharma, and chemical industries are struggling to attract LC experts. Overall, the level of analytical expertise is declining at a frightening speed. This trend, combined with the development of new biotherapies, puts stress on the industry. Part of the solution is the development of robust and easy-to-use instruments, as well as software guided approaches to LC method development. Still, somebody will have to pick up the education slack – and this may be an opportunity for the next generation of entrepreneurs.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

Recommended

False

False

The Analytical Scientist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.